Cognia Earns Phase I SBIR Award to Develop A Protein Catabolism Database Resource | GenomeWeb

Backed by a one-year, $100,000 SBIR grant from the National Institutes for General Medical Sciences, Cognia is embarking on the development of a protein catabolism database and software system, its first in-house commercial offering.

Though it was established in 1999, all of Cognia’s revenue until now has been through its marketing agreements with other bioinformatics tools and database companies. It currently holds North American distribution rights for the Transfac transcription factor database and other products developed by Biobase of Braunschweig, Germany.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.